← All themes

Genomics & Gene Editing

Genomics reads the genetic code and gene editing rewrites it, which can turn an inherited disease from a lifelong condition into a single treatment. Sequencing cost has fallen far enough to make study at population scale routine.

199 stocks

Gene Therapy

#	Name	Holding	Trade Value	% of Portfolio	Status
1951	PC Paulson & Co New York	$0	-$381M	–	Closed
1952	PFG Piershale Financial Group Barrington, Illinois	$0	-$2.13M	–	Closed
1953	QSS Quantitative Systematic Strategies Ponte Vedra Beach, Florida	$0	-$1.88M	–	Closed
1954	QAM Quantres Asset Management Cayman, Cayman Islands	$0	-$1.41M	–	Closed
1955	RSCM Rail-Splitter Capital Management Chicago, Illinois	$0	-$6.84M	–	Closed
1956	SC Sophrosyne Capital New York	$0	-$508K	–	Closed
1957	SAM Strategy Asset Managers Pasadena, California	$0	-$3.21M	–	Closed
1958	SC Sumit Capital New York	$0	-$219K	–	Closed
1959	SPM Symmetry Peak Management Radnor, Pennsylvania	$0	-$1.34M	–	Closed
1960	T TOBAM Paris, France	$0	-$1.76M	–	Closed
1961	TWM Torch Wealth Management Cincinnati, Ohio	$0	-$160K	–	Closed
1962	TCM Twin Capital Management Mcmurray, Pennsylvania	$0	-$567K	–	Closed
1963	TCM Tygh Capital Management Portland, Oregon	$0	-$1.02M	–	Closed
1964	VNB Valley National Bancorp New York	$0	-$16K	–	Closed
1965	VAM Verity Asset Management Durham, North Carolina	$0	-$196K	–	Closed
1966	Waratah Capital Advisors Toronto, Ontario, Canada	$0	-$441K	–	Closed
1967	WAM Westport Asset Management Southport, Connecticut	$0	-$1.42M	–	Closed
1968	WAS Winch Advisory Services Appleton, Wisconsin	$0	-$683K	–	Closed
1969	YCM Yakira Capital Management Westport, Connecticut	$0	-$172K	–	Closed
1970	YP Yellowstone Partners Idaho Falls, Idaho	$0	-$840K	–	Closed
1971	ZWJ Investment Counsel Atlanta, Georgia	$0	-$217K	–	Closed